BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide derived from a protective protein naturally present in human gastric juice. It is commonly described in the scientific literature as a stable gastric pentadecapeptide, reflecting both its biological origin and its unusual stability under experimental conditions.

Unlike many regenerative peptides that originate from endocrine or immune signalling, BPC-157 emerged from gastrointestinal research before becoming widely investigated across musculoskeletal, vascular and connective tissue biology.

Today it is one of the most extensively studied experimental peptides in regenerative research, particularly in models involving soft-tissue repair, angiogenesis and cytoprotective signalling.

Why BPC-157 matters in regenerative research

One of the reasons BPC-157 has attracted so much scientific interest is the breadth of tissues and biological systems investigated in experimental research. Published studies have explored BPC-157 in relation to:

tendon repair
ligament healing
skeletal muscle biology
joint and connective tissue research
angiogenesis
gastrointestinal protection
inflammatory signalling
nitric oxide pathways
peripheral nerve research
soft-tissue regeneration

Because tendon, ligament and muscle injuries are common in physically active populations, BPC-157 has also become one of the most recognised peptides in sports medicine and musculoskeletal recovery research, although the majority of published evidence remains preclinical. Although these findings have generated considerable interest, most of the available evidence comes from laboratory and animal studies rather than large human clinical trials.

How BPC-157 works

Unlike peptides that primarily activate a single receptor, BPC-157 appears to influence several interconnected biological pathways involved in tissue repair. Published experimental research has investigated its relationship with:

Angiogenesis

Formation of new blood vessels and vascular repair signalling.

Nitric oxide pathways

Modulation of nitric oxide systems involved in vascular function and tissue repair.

Tendon and connective tissue biology

Studies have explored fibroblast activity, collagen organisation and tendon healing responses following injury.

Cytoprotection

Research has also examined protective effects in gastrointestinal tissues together with broader cellular stress responses.

Rather than representing one isolated mechanism, BPC-157 is generally investigated as a peptide influencing multiple aspects of regenerative biology simultaneously.

What makes BPC-157 different from other regenerative peptides?

Although BPC-157, TB-500 and GHK-Cu are often grouped together within regenerative research, they represent different biological approaches.

BPC-157

Stable gastric pentadecapeptide
Soft-tissue and musculoskeletal research
Tendon and ligament biology
Angiogenesis
Nitric oxide signalling
Cytoprotection

TB-500

Thymosin β4 biology
Cell migration
Actin dynamics
Tissue remodelling

GHK-Cu

Endogenous copper peptide
Collagen biology
Extracellular matrix regulation
Skin and connective tissue physiology

Rather than competing directly, these peptides are frequently discussed together because they target different aspects of tissue repair and regenerative biology.

Published safety observations

Published experimental studies have generally reported favourable safety findings for BPC-157 within the investigated models.

However, compared with its extensive laboratory literature, human clinical evidence remains limited. Current understanding of BPC-157 therefore relies predominantly on preclinical research, and findings should be interpreted within that context.

Frequently Asked Questions

What is BPC-157?

BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide derived from a protective protein naturally present in human gastric juice. It is widely recognised in regenerative research for studies involving tissue repair, tendon and ligament biology, angiogenesis and gastrointestinal protection. Because of its broad experimental research profile, BPC-157 has become one of the best-known peptides in musculoskeletal and regenerative biology.

Why is BPC-157 called a stable gastric pentadecapeptide?

The term “stable gastric pentadecapeptide” reflects both the origin and the structure of BPC-157. It is derived from a naturally occurring protective gastric protein, contains 15 amino acids (hence pentadecapeptide), and demonstrates unusual stability under experimental conditions compared with many other peptides. These characteristics originally made it an important subject in gastrointestinal research before its investigation expanded into connective tissue and regenerative biology.

Why is BPC-157 widely investigated in tendon and ligament research?

Published experimental studies have investigated BPC-157 in numerous models involving tendons, ligaments, muscles and other connective tissues. Researchers have explored its relationship with angiogenesis, fibroblast activity, collagen organisation and tissue repair processes, making it one of the most frequently discussed peptides in musculoskeletal and sports medicine research. Although these findings have generated considerable interest, the majority of available evidence comes from laboratory and animal studies rather than large human clinical trials.

How does BPC-157 differ from TB-500?

Although both peptides are frequently associated with regenerative research, they have different biological backgrounds. BPC-157 originated from gastrointestinal research and is commonly investigated in tendon, ligament, muscle, vascular and cytoprotective models. TB-500 is associated with Thymosin β4 biology and is more closely linked to cell migration, actin dynamics and tissue remodelling. Rather than being direct alternatives, they are often viewed as complementary research tools.

How does BPC-157 differ from GHK-Cu?

GHK-Cu is a naturally occurring copper-binding tripeptide primarily investigated for extracellular matrix regulation, collagen biology, skin physiology and connective tissue remodelling. BPC-157, by comparison, is more commonly studied in soft-tissue repair, musculoskeletal research, gastrointestinal protection and angiogenesis. While both appear in regenerative research, they target different biological pathways and research questions.

What research areas commonly investigate BPC-157?

Published research has investigated BPC-157 across a broad range of experimental models, including tendon and ligament biology, skeletal muscle, gastrointestinal protection, angiogenesis, peripheral nerve research, nitric oxide signalling, inflammatory pathways and connective tissue repair. This broad research profile is one of the reasons BPC-157 remains one of the most widely recognised regenerative peptides.

Is this product intended for human use?

No. BPC-157 supplied by LIFE Peptide is provided strictly for laboratory and analytical research. It is not intended for human consumption, diagnosis, treatment or prevention of disease. Any discussion of published studies on this page is included to summarise the current scientific literature relating to the BPC-157 molecule and should not be interpreted as instructions or recommendations for use.

Product characteristics

Application: laboratory and analytical research
Use restriction: not for human consumption; not for medical, veterinary or cosmetic use
Produced in GMP-compliant facilities under strict QC protocols.
Each batch carefully lab tested after production (you can find Certificate of Analysis under product pictures).
Freeze-dried (lyophilized) for maximum stability and extended shelf life.
Sealed in sterile vials, ready for reconstitution.
Purity: ≥98.8% (HPLC-tested)
Appearance: Lyophilized white/off-white powder
Molecular formula: C₆₂H₉₈N₁₆O₂₂
Molecular weight: 1419.54 g/mol
Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Storage: unopened lyophilized vials are best stored refrigerated at 2–8°C, which is the storage method confirmed by our manufacturing partner and suitable for up to 24 months. Refrigeration is preferred because it minimizes unnecessary freeze–thaw cycles during routine handling. If substantially longer-term storage is required, unopened lyophilized vials may also be kept frozen. Once reconstituted, always store at 2–8°C and do not freeze.

Reconstitution and handling

BPC-157 is supplied as a lyophilised vial and should be handled using standard peptide reconstitution procedures appropriate to the research setting. Must be reconstituted with bacteriostatic water before use. To help preserve structural integrity, add the chosen solvent slowly against the inside wall of the vial rather than directly onto the peptide cake, and avoid vigorous shaking. Gentle swirling is generally sufficient once the peptide has fully dissolved. Standard laboratory practice also includes allowing refrigerated vials to reach room temperature before reconstitution to minimise condensation inside the vial.

For other solvent selection, concentration planning and storage guidance, see the full Peptide Reconstitution Guide and Reconstitution Calculator.

Key published studies

Sikiric P, Seiwerth S, Rucman R, et al. Stable Gastric Pentadecapeptide BPC 157: Novel Therapy in Gastrointestinal Tract. Current Pharmaceutical Design, 2011.

A landmark review describing the origin of BPC-157, its remarkable stability and the broad range of gastrointestinal and regenerative research conducted on the peptide.

Chang CH, Tsai WC, Hsu YM, et al. Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts. Molecular Medicine Reports, 2014.

A key mechanistic study demonstrating enhanced growth hormone receptor expression and fibroblast activity, helping explain BPC-157’s importance in tendon biology.

Cerovecki T, Bojanic I, Brcic L, et al. Pentadecapeptide BPC 157 Improves Ligament Healing in an Experimental Model. Journal of Orthopaedic Research, 2010.

One of the landmark musculoskeletal studies investigating ligament healing, biomechanical recovery and connective tissue regeneration.

Sikiric P, Seiwerth S, Grabarevic Z, et al. The Stable Gastric Pentadecapeptide BPC 157 and the Brain–Gut Axis. Current Neuropharmacology, 2016.

A comprehensive review exploring BPC-157 across gastrointestinal, neurological, vascular and regenerative research.

Related research context

BPC-157 is part of the peptide-based healing and tissue repair research class, commonly studied in models involving angiogenesis, extracellular matrix remodeling, and soft-tissue recovery. For broader context on regenerative pathways and compound interactions, see our Healing & recovery research guide.

Browse all compounds in the Healing & recovery research category.
Researchers investigating multi-pathway tissue repair and regenerative signaling may also examine:
Thymosing b4 (TB-500) (full sequence) – actin regulation and cellular migration
GHK-Cu (copper peptide complex) – tissue remodeling and collagen-related pathways
KPV (α-MSH fragment) – inflammation-modulating peptide fragment
ARA-290 — erythropoietin-derived tissue protection research
SS-31 – investigated for mitochondrial function and cellular energy production.

NOTE: This is for educational reference only and does not constitute medical advice.

Disclaimer:
This product is sold for research purposes only. It is not intended to diagnose, treat, cure, or prevent any disease. Buyer assumes full responsibility for proper handling and use.

BPC-157

BPC-157 / 5 mg